These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25737447)

  • 1. MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence.
    Cho JH; Dimri M; Dimri GP
    J Biol Chem; 2015 Apr; 290(16):10555-67. PubMed ID: 25737447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
    Dimri M; Kang M; Dimri GP
    Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
    Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
    Gergely JE; Dorsey AE; Dimri GP; Dimri M
    Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts.
    Dimri M; Carroll JD; Cho JH; Dimri GP
    Cell Cycle; 2013 Nov; 12(22):3537-46. PubMed ID: 24091627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
    Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
    Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines.
    Henrici A; Montalbano R; Neureiter D; Krause M; Stiewe T; Slater EP; Quint K; Ocker M; Di Fazio P
    Mol Carcinog; 2015 Aug; 54(8):585-97. PubMed ID: 24375802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
    Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells.
    Wang S; Huang J; Lyu H; Lee CK; Tan J; Wang J; Liu B
    Cell Death Dis; 2013 Mar; 4(3):e556. PubMed ID: 23519125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epigenetic regulation of Dicer and microRNA biogenesis by Panobinostat.
    Hoffend NC; Magner WJ; Tomasi TB
    Epigenetics; 2017 Feb; 12(2):105-112. PubMed ID: 27935420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.
    Dimri M; Cho JH; Kang M; Dimri GP
    J Biol Chem; 2015 Jan; 290(5):3033-44. PubMed ID: 25505268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
    LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
    BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.
    Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
    J Biol Chem; 2014 Feb; 289(7):4116-25. PubMed ID: 24371144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes.
    Wang JH; Shih KS; Wu YW; Wang AW; Yang CR
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1987-96. PubMed ID: 24107356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster.
    Humphreys KJ; Cobiac L; Le Leu RK; Van der Hoek MB; Michael MZ
    Mol Carcinog; 2013 Jun; 52(6):459-74. PubMed ID: 22308110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    M JR; S V
    Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect.
    Yamada M; Ikeda S; Kuroki W; Iwama S; Takahashi Y; Kitadate A; Tagawa H; Takahashi N
    Int J Hematol; 2024 Sep; 120(3):325-336. PubMed ID: 38954186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells.
    Mazzio EA; Soliman KF
    Cancer Genomics Proteomics; 2017 Jan; 14(1):17-33. PubMed ID: 28031235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.
    Ferreira AC; Robaina MC; Rezende LM; Severino P; Klumb CE
    Ann Hematol; 2014 Jun; 93(6):983-93. PubMed ID: 24577510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.
    Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M
    Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.